- Home
- WEC vs GEHC Comparison
WEC vs GEHC Comparison
Compare WEC & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WEC | GEHC |
|---|---|---|
| Founded | 1896 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Computer Software: Prepackaged Software |
| Sector | Utilities | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.2B | 29.1B |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | WEC | GEHC |
|---|---|---|
| Price | $101.73 | $63.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 20 |
| Target Price | ★ $121.62 | $83.05 |
| AVG Volume (30 Days) | 2.3M | ★ 3.0M |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | ★ 3.78% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | ★ 4.81 | 0.85 |
| Revenue | $9,800,100,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | $4.79 | $5.32 |
| Revenue Next Year | $5.26 | $4.60 |
| P/E Ratio | ★ $21.41 | $78.09 |
| Revenue Growth | ★ 13.96 | 4.84 |
| 52 Week Low | $100.14 | $58.75 |
| 52 Week High | $119.91 | $89.77 |
Technical Indicators
Market Signals| Indicator | WEC | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 31.34 | 41.03 |
| Support Level | N/A | $60.17 |
| Resistance Level | $107.42 | $66.20 |
| Average True Range (ATR) | 1.48 | 1.17 |
| MACD | -0.13 | 0.18 |
| Stochastic Oscillator | 3.82 | 53.23 |
Price Performance
Historical ComparisonAbout WEC WEC Energy Group Inc.
WEC Energy Group's electric and gas utility businesses serve electric and gas customers in Illinois, Michigan, Minnesota, and Wisconsin service territories. The company also owns a 60% stake in American Transmission Co. WEC's asset mix is approximately 49% electric generation and distribution, 30% gas distribution, 10% electric transmission, 9% unregulated renewable energy, and 2% LNG distribution and generation.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).